Stephen Clarke

Stephen Clarke

University of Sydney - Sydney / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1246
person_outline Stephen Clarke's MOST POPULAR ARTICLES
1-) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study Journal of clinical oncology 26 (12), 2013-2019, 2008
2-) Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study The Lancet Oncology 18 (10), 1386-1396, 2017
3-) The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer Critical reviews in oncology/hematology 88 (1), 218-230, 2013
4-) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer Journal of clinical oncology 26 (12), 2006-2012, 2008
5-) Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial The lancet oncology 13 (12), 1225-1233, 2012